The BiosearchTech Blog

As countries worldwide begin to ease lockdown restrictions during the pandemic and prepare to return to “normal” without a vaccine for COVID-19 or effective treatments in place, prudent testing measures need to be taken to suppress new infections. It is critical to test more people rapidly to identify who is infected, track them to avoid the disease from spreading and tracing with whom they have been in contact. Reverse transcription PCR (RT-PCR) testing method currently represents the majority of COVID-19 molecular diagnostics that helps identify individuals who are infected at the time of the test.

Read More

It may seem strange that a company known for transforming the global seed breeding industry is uniquely positioned to help COVID-19 testing labs overcome bottlenecks and rapidly scale-up testing. However, when you look at the problems testing labs are facing, it becomes clear that LGC, Biosearch Technologies has all the right tools for a rapid and robust pandemic response, even with the need to validate our Research Use Only (RUO) products for diagnostic testing. Today’s significantly altered conditions require new approaches and new solutions. Read on to learn how equipment that originally helped  to transform genetic selection in plant breeding is now central to an accepted EUA submission for high throughput COVID testing to provide unparalleled levels of test capacity to meet the critical demand we currently face.

Read More

It seems everyone wants to do more with less, and automate the process as well.  But this can cause a number of challenges for even a traditional molecular diagnostics tool such as PCR.

Read More